Managed a wide variety of complex consultation requests for investors, small drug companies and attorneys which include various safety and efficacy analyses of clinical study proposals, reports, product labeling NDAs, End of Phase 2 go/no go criteria, new protocols and protocol amendments. • Composed detailed, comprehensive and thoroughly-referenced scientific/clinical reports and analyses. • Provided attorney/witness preparation and personally provided expert depositions for a wide rage of cases, anywhere from small physician malpractice suits and patent declarations, to multibillion class-action litigation lawsuits. • Prepared and provided formal presentations of clinical and pharmacology data to lay population of (financial analysts, individual investors, board of director panels, attorneys, et cetera) • Over a decade of top-tier Medical School didactic pharmacology lecturing experience, (Yale Unive

Pharmacology & Clinical Toxicology.